Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and the leading cause of chronic liver disease in the Western world. Twenty per cent of NAFLD individuals develop chronic hepatic inflammation (non-alcoholic steatohepatitis, NASH) associated with cirrhosis, portal hypertension and hepatocellular carcinoma, yet the causes of progression from NAFLD to NASH remain obscure. Here, we show that the NLRP6 and NLRP3 inflammasomes and the effector protein IL-18 negatively regulate NAFLD/NASH progression, as well as multiple aspects of metabolic syndrome via modulation of the gut microbiota. Different mouse models reveal that inflammasome-deficiency-associated changes in the configuration of the gut microbiota are associated with exacerbated hepatic steatosis and inflammation through influx of TLR4 and TLR9 agonists into the portal circulation, leading to enhanced hepatic tumour-necrosis factor (TNF)-a expression that drives NASH progression. Furthermore, co-housing of inflammasome-deficient mice with wild-type mice results in exacerbation of hepatic steatosis and obesity. Thus, altered interactions between the gut microbiota and the host, produced by defective NLRP3 and NLRP6 inflammasome sensing, may govern the rate of progression of multiple metabolic syndrome-associated abnormalities, highlighting the central role of the microbiota in the pathogenesis of heretofore seemingly unrelated systemic auto-inflammatory and metabolic disorders.
Results
Feeding adult mice a methionine-choline-deficient diet (MCDD) for 4 weeks beginning at 8 weeks of age induces several features of human NASH, including hepatic steatosis, inflammatory cell infiltration and ultimately fibrosis 15 . To investigate the role of inflammasomes in NASH progression, we fed MCDD to C57Bl/6 wild type (NCI), apoptosis-associated speck-like protein containing a CARD (Asc 2/2 , also known as Pycard) and caspase 1 (Casp1 2/2 ) mutant mice to induce early liver damage in the absence of fibrosis ( Fig. 1a-d and Supplementary Fig. 1c ). Compared to wild-type animals, age-and gender-matched Asc 2/2 and Casp1 2/2 mice that were fed MCDD were characterized by significantly higher serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activity, by enhanced microvesicular and macrovesicular hepatic steatosis, and by accumulation of multiple immune subsets in the liver from the innate and adaptive arms of the immune system (as defined by pathological examination and flow cytometry; n 5 7-11 mice per group; Fig. 1a-d and Supplementary Figs 1c, 2a) . Remarkably, the hepatic accumulation of T and B cells seems to be dispensable for this phenotype because Asc 2/2 mice lacking adaptive immune cells (Asc 2/2 ; Rag 2/2 ) also showed more severe NASH compared to wild-type animals, and comparable degrees of pathology to Asc 2/2 animals ( Supplementary Fig. 2b-d) .
To test whether the increased NASH observed in Asc-and Casp1deficient mice was mediated by IL-1b or IL-18, we performed similar experiments using mice deficient in either the IL-1 receptor (Il1r 2/2 ) or IL-18 (Il18 2/2 ). Il1r 2/2 mice did not show any changes in the severity of NASH when compared to wild-type mice when fed MCDD ( Supplementary Fig. 1a, b) . In contrast to, but similar to Asc 2/2 and Casp1 2/2 mice, MCDD-fed Il18 2/2 animals featured a significant exacerbation of NASH severity (Fig. 1g , h and Supplementary Fig. 1c ).
To assess the role of the NLRP3 inflammasome in NASH progression, we fed singly housed Nlrp3 2/2 and wild-type animals MCDD for 24 days and evaluated disease progression. Nlrp3 2/2 mice developed exacerbated NASH compared to wild-type mice as judged by increased levels of serum ALT and AST, plus NAFLD activity inflammation scores (Fig. 1e, f and Supplementary Fig. 1c ). Remarkably, bone marrow chimaeric mice in which NLRP3 and ASC deficiency was limited to the haematopoietic compartment did not show any increase in the severity of NASH when compared to wild-type mice reconstituted with wild-type bone marrow (Supplementary Fig. 3a-f ). Likewise, knock-in mice that specifically express a constitutively active NLRP3 inflammasome in CD11c 1 myeloid cells (Nlrp3KI; CD11c 1 -Cre) or hepatocytes (Nlrp3KI; albumin-Cre) 16 did not feature any significant differences in MCDDinduced NASH severity as compared to wild-type mice (Supplementary Fig. 3g-l) . These results indicate that aberrations in inflammasome function in cells other than hepatocytes or myeloid cells are key determinants of the enhanced disease progression in inflammasomedeficient mice.
We recently discovered that inflammasomes act as steady-state sensors and regulators of the colonic microbiota, and that a deficiency in components of two inflammasomes, NLRP6 (ref. 17 ) and NLRP3 (unpublished), both of which include ASC and caspase 1, and involve IL-18 but not IL-1R, results in the development of an altered transmissible, colitogenic intestinal microbial community 17 . This microbiota is associated with increased representation of members of Bacteroidetes (Prevotellaceae) and the bacterial phylum TM7, and reductions in representation of members of the genus Lactobacillus in the Firmicutes phylum 17 . Moreover, electron microscopy studies disclosed aberrant colonization of crypts of Lieberkühn with bacteria with morphologic features of Prevotellaceae 17 . Therefore, we sought to investigate whether enhanced NASH severity in inflammasomedeficient mice is driven by their altered microbiota. Strikingly, cohousing of Asc 2/2 and Il18 2/2 mice with wild-type animals for 4 weeks (beginning at 4-6 weeks of age), before induction of NASH with MCDD resulted in significant exacerbation of NASH in the wild-type cage-mates (which we will refer to as WT(Asc 2/2 ) and WT(Il18 2/2 ), respectively, in the following text), as compared to singly housed, age-and gender-matched wild-type controls (n 5 5-7 mice per genotype per housing condition). In co-housed wild-type mice, disease severity reached comparable levels to that of co-housed Asc 2/2 and Il18 2/2 mice ( Fig. 2a-h) . Moreover, significantly increased numbers of multiple inflammatory cell types were present in the liver of WT(Asc 2/2 ) compared to wild-type mice ( Supplementary Fig. 2a ). Similar findings were observed in wild-type mice co-housed with Casp1 2/2 , Nlrp3 2/2 and Nlrp6 2/2 mice ( Supplementary Fig. 4a -f). To exclude the possibility that aberrant microbiota presented in all mice maintained in our vivarium, we cohoused wild-type mice with other strains of NLR-deficient mice that were either obtained from the same source as Asc 2/2 and Nlrp3 2/2 mice (Nlrc4 2/2 , Nlrp12 2/2 ), or generated in our laboratory (Nlrp4c 2/2 ). None of these strains featured a similar phenotype ( Supplementary Fig. 4g -l). These results indicate that the transmissible colitogenic microbiota present in inflammasome-deficient mice is a major contributor to their enhanced NASH. In agreement with this, combined antibiotic treatment with ciprofloxacin and metronidazole, previously shown to abrogate the colitogenic activity
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Asc -/-(WT) Figure 2 | Increased severity of NASH in Ascand Il18-deficient mice is transmissible to co-housed wild-type animals. Asc 2/2 or Il18 2/2 mice and wild-type mice were co-housed for 4 weeks and then fed MCDD. a-d, ALT (a), AST (b), NAFLD activity scores (c), and haematoxylin and eosin-stained sections of livers (d) of singly housed wild-type mice (WT), wild-type mice cohoused with Asc 2/2 mice (WT(Asc 2/2 )), and Asc 2/2 mice co-housed with wild-type mice (Asc 2/2 (WT)). e-h, ALT (e), AST (f), NAFLD activity histological scores (g), and haematoxylin and eosin-stained sections of livers (h) of wild-type, WT(Il18 2/2 ) and 
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of the microbiota associated with inflammasome-deficient mice associated microbiota 17 , significantly reduced the severity of NASH in Asc 2/2 mice, and abolished transmission of the phenotype to WT(Asc 2/2 ) animals ( Supplementary Fig. 5 ).
To ascertain the effects of MCDD on the gut microbiota, we performed a culture-independent analysis of amplicons generated by primers directed against variable region 2 of bacterial 16S ribosomal RNA genes of faecal samples collected from wild-type mice co-housed with Asc 2/2 animals (WT(Asc 2/2 )), their Asc 2/2 cage-mates (Asc 2/2 (WT)) as well as singly housed wild-type controls 1 day and 12 days before, and 7, 14 and 19 days after initiation of this diet (n 5 20 animals; 8 singly housed wild-type, 6 co-housed wild-type and 6 Asc 2/2 mice). The structures of bacterial communities were compared based on their phylogenetic content using unweighted UniFrac. The results are illustrated in Fig. 3 . Supplementary Table 1 provides a list of all phylotypes that, based on criteria outlined in Methods, discriminate co-housed WT(Asc 2/2 ) from their singly housed wild-type counterparts. Prior to MCDD, and consistent with our previous findings 17 , the faecal microbiota of WT(Asc 2/2 ) mice adopted a configuration similar to Asc 2/2 cage-mates, including the appearance of Prevotellaceae (Supplementary Table 1 and Fig. 3 
a-c).
There was also a significant increase in proportional representation of members of the family Porphyromonadaceae (primarily in the genus Parabacteroides) in WT(Asc 2/2 ) mice compared to their singly housed wild-type counterparts ( Fig. 3d,e ). The representation of Porphyromonadaceae was greatly increased in both the co-housed wild-type and Asc 2/2 mice (but not in singly housed wild-type) when they were switched to a MCDD diet (P , 0.01; t-test; Fig. 3d ). A dramatic increase in the family Erysipelotrichaceae (phylum Firmicutes) also occurred with MCDD in both singly and co-housed WT animals, to a level that was .10% of the community (Fig. 3f ). Although the Prevotellaceae decreased when co-housed WT(Asc 2/2 ) mice were placed on MCDD, their relative abundance remained significantly higher than in singly housed wild-type animals ( Fig. 3c ).
Together, these results pointed to the possibility that members of the altered intestinal microbiota in inflammasome-deficient MCDDtreated mice may promote a signalling cascade in the liver upon translocation, resulting in progression to NASH in susceptible animals. Toll-like receptors (TLR) have a major role in NAFLD pathophysiology due to the liver's exposure to relatively large amounts of PAMPs derived from the intestine and delivered via the portal circulation [18] [19] [20] . Therefore, we propose that TLR signalling mediates the increased susceptibility to progression to NASH in mice exposed to the gut microbiota of Asc 2/2 animals. Myd88 2/2 ;Trif 2/2 mice are devoid of all TLR signalling pathways. When co-housed with Asc 2/2 (Myd88 2/2 ;Trif 2/2 (Asc 2/2 ))mice between 5 and 9 weeks of age, they showed decreased severity of NASH after exposure to MCDD for 24 days, compared to WT(Asc 2/2 ) mice ( Supplementary Fig. 6a, b ). 
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To define which specific TLRs were responsible for the inflammatory response, we co-housed Tlr4-, Tlr9-or Tlr5-deficient mice with Asc 2/2 animals and induced NASH with MCDD as previously described. Similar to wild-type mice, Tlr5 2/2 mice co-housed with Asc 2/2 mice (Tlr5 2/2 (Asc 2/2 )) featured a statistically significant exacerbation of hepatic injury, steatosis and inflammation, when compared to singly housed Tlr5 2/2 controls ( Fig. 4c and Supplementary Fig. 6g, h) , indicating that TLR5 does not mediate the microbiota-mediated exacerbation in disease severity. In contrast, Tlr4 2/2 (Asc 2/2 ) and Tlr9 2/2 (Asc 2/2 ) mice did not show the customary increase in disease severity when compared to their singly housed Tlr4 2/2 and Tlr9 2/2 counterparts (Fig. 4a, b and Supplementary Fig. 6c-f ).
These observations indicate that intact bacteria or bacterial products derived from the intestine trigger TLR4 and TLR9 activation, which results in an increased rate of disease progression in mice that house a colitogenic gut microbiota associated with inflammasome deficiency (that is, Asc 2/2 and WT(Asc 2/2 ) mice). Efforts to sequence 16S rRNA genes that might be present in total liver DNA, microbial quantitative PCR assays of portal vein blood DNA, histologic analysis of intact liver, and aerobic and anaerobic cultures of liver homogenates did not reveal any evidence of intact bacteria in wild-type or Asc 2/2 mice fed MCDD (data not shown). Notably, transmission electron microscopy studies of colon collected from wild-type and Asc 2/2 mice revealed an abundance of electron-dense material, suggestive of some black-pigmented bacterial species, in colonic epithelial cells and macrophages located in the lamina propria of Asc 2/2 mice but not in wild-type animals ( Fig. 4e and Supplementary Fig. 7c ). In agreement with previous results, we did not detect any translocation of intact bacteria ( Fig. 4e and Supplementary Fig. 7c ).
These observations provide evidence for the uptake of bacterial products from locally invasive gut microbes in Asc 2/2 mice ( Fig. 4e and Supplementary Fig. 7c ). If microbial components, rather than whole organisms, were transmitted to the liver then they should be detectable in the portal circulation. Indeed, levels of TLR4 and TLR9 agonists, but not TLR2 agonists (assayed by their ability to activate TLR reporter cell lines), were markedly increased in the portal circulation of MCDD-fed WT(Asc 2/2 ), and Asc 2/2 mice compared to wild-type controls (n 5 13-28 mice per group; Fig. 4d and Supplementary Fig. 7a, b) . Altogether, these results indicate a mechanism whereby TLR4 and TLR9 agonist efflux from the intestines of inflammasome-deficient mice or their co-housed partners, through the portal circulation, to the liver where they trigger TLR4 and TLR9 activation that in turn results in enhanced progression of NASH.
We next explored the downstream mechanism whereby microbiota-induced TLR signalling enhances NASH progression. Proinflammatory cytokines, and in particular TNF-a, a downstream cytokine of TLR signalling, are known to contribute to progression of hepatic steatosis to steatohepatitis and eventually hepatic fibrosis in a number of animal models and in human patients 21, 22 . Following induction of NASH by MCDD, hepatic Tnf mRNA expression was significantly upregulated in Asc 2/2 and Il18 2/2 mice, which show exacerbated disease, but not in Il1r 2/2 mice, which do not (Supplementary Fig. 8a-c) . Moreover, Tnf mRNA levels were significantly increased in wild-type mice that had been previously co-housed with Asc 2/2 or Il18 2/2 mice and then fed MCDD ( Supplementary  Fig. 8d, e ), indicating that its enhanced expression was mediated by elements of the microbiota responsible for NASH exacerbation. In contrast, we did not observe any changes in Il6 or Il1b mRNA levels in the livers of Asc 2/2 , Il18 2/2 or Il1r 2/2 mice compared to wild-type controls ( Supplementary Fig. 8a-c) . Furthermore, whereas MCDDadministered singly housed Tnf 2/2 mice had comparable NASH severity to singly housed wild-type animals (Fig. 4f-h and Supplementary Fig. 8f ), co-housing with Asc-deficient mice before MCDD induction of NASH resulted in increased liver injury, hepatic steatosis and inflammation in wild-type mice but not in Tnf 2/2 mice (Fig. 4f-h and Supplementary Fig. 8f ). These results indicate that TNFa mediates the hepatotoxic effects downstream of the transmissible gut microbiota present in Asc 2/2 mice.
The aberrant gut microbiota in NLRP3 and NLRP6 inflammasomedeficient mice induces colonic inflammation through epithelial induction of CCL5 secretion 17 . To test whether this colon inflammation influences TLR agonist influx into the portal circulation and NASH progression, we induced NASH in wild-type and Ccl5 2/2 mice that had been either singly housed or co-housed. MCDD-fed, singly housed wild-type and Ccl5 2/2 mice showed equivalent levels of NASH severity ( Supplementary Fig. 9a-c) , indicating that CCL5 does not have a role in the early stages of NAFLD/NASH in the absence of the inflammasome-associated colitogenic microbiota. However, we documented significantly increased levels of liver injury, inflammation and steatosis in WT(Asc 2/2 ) but not Ccl5 2/2 (Asc 2/2 ) mice ( Fig. 5a-c) , which led us to conclude that CCL5 is required for the exacerbation of disease through cohousing with inflammasome-deficient mice. Moreover, Ccl5 2/2 (Asc 2/2 ) animals showed significantly reduced levels of TLR4 and TLR9 agonists in their portal vein blood than WT(Asc 2/2 ) mice ( Supplementary Fig. 9d-f ). Together, these results 
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indicate that microbiota-induced subclinical colon inflammation is a determining factor in the rate of TLR agonist influx from the gut, and in NAFLD/NASH progression.
The MCDD system is a common model for studying inflammatory processes associated with progression from NAFLD to NASH, yet it lacks many of the associated metabolic phenotypes of NAFLD, such as obesity and insulin resistance 23 . As such, our results in this model might conceivably be limited to the way dysbiosis can influence NASH progression in patients with enhanced intestinal permeability, such as those with inflammatory bowel disease 24 , but not for the majority of patients who suffer from NASH in the context of metabolic syndrome. To test whether alterations in the gut microbiota of inflammasome-deficient mice may affect the rate of progression of NAFLD and other features associated with metabolic syndrome, we extended our studies to genetically obese mice and mice fed with highfat diet (HFD).
Leptin-receptor deficient (db/db; db is also known as Lepr) animals develop multiple metabolic abnormalities, including NAFLD and impaired intestinal barrier function 25 , that closely resemble the human disease 26 . However, significant hepatocyte injury, inflammation, and fibrosis are not observed in the absence of a ''second hit'' 27 . Upon co-housing of db/db mice with Asc 2/2 (db/db(Asc 2/2 )) or WT mice (db/db(WT)) for a period of 12 weeks, and as previously shown for Asc 2/2 mice 17 , the colon and ileum of all db/db(Asc 2/2 ) mice showed mild to moderate mucosal and crypt hyperplasia ( Fig. 5d-f ) that was not seen in db/db(WT) mice.
Strikingly, co-housed db/db(Asc 2/2 ) mice also showed increased levels of hepatocyte injury as evidenced by higher levels of ALT and AST in their sera, and significantly exacerbated steatosis and hepatic inflammation scores when compared with db/db(WT) mice ( Fig. 5g-i) . In addition to a parenchymal inflammatory exudate, patchy areas of markedly degenerated hepatocytes and hepatocytes undergoing necrosis were observed, but only in db/db(Asc 2/2 ) animals ( Fig. 5f ). Furthermore, some areas of congestion were seen in the centro-lobular zone as well as in the hepatic parenchyma -features that resemble peliosis hepatis, a condition observed in a variety of pathological settings including infection (data not shown). In accord with our MCDD results, hepatic Tnf mRNA levels were significantly higher in co-housed db/db(Asc 2/2 ) mice than in db/db(WT) animals (Fig. 5j) . Again, no significant differences were observed in hepatic Il6 or Il1b mRNA levels (Fig. 5j) .
Interestingly, db/db(Asc 2/2 ) mice developed significantly more weight gain compared to db/db(WT) mice after 12 weeks of co-housing ( Fig. 6a) , indicating that the inflammasome-associated gut microbiota could exacerbate additional processes associated with the metabolic syndrome, such as obesity. To address this possibility, we monitored multiple metabolic parameters in wild-type, WT(Asc 2/2 ) and Asc 2/2 mice fed a high-fat diet (HFD) for 12 weeks. Strikingly, Asc 2/2 mice gained body mass more rapidly and featured enhanced hepatic steatosis (Fig. 6b, c and Supplementary Fig. 11f ). Asc 2/2 mice also showed elevated fasting plasma glucose and insulin levels, and decreased glucose tolerance compared to singly housed weight-matched wildtype mice (Fig. 6d-f ). Interestingly, WT(Asc 2/2 ) mice recapitulated 
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the same increased rate of body mass gain and steatosis when compared to singly housed wild-type controls, although they did not show significant alterations in glucose homeostasis ( Fig. 6d-f ). Nevertheless, antibiotic treatment (ciprofloxacin and metronidazole) abrogated all these abnormalities, including altered rate of gain in body mass, glucose intolerance and fasting plasma insulin levels in Asc 2/2 mice compared to wild-type mice ( Fig. 6g-j) . Alterations of these metabolic parameters were not caused by changes in feeding behaviour between the antibiotic-treated and untreated groups (data not shown). These results indicate different levels of microbiota-mediated regulation of the various manifestations of the metabolic syndrome: that is, some features (obesity, steatosis) are pronounced and transmissible by cohousing, whereas others (glycaemic control) are affected by alterations in the microbiota but not readily transferable by co-housing. Additionally, we performed a 16S rRNA-based analysis of the faecal microbiota of Asc 2/2 and wild-type animals that were treated with or without ciprofloxacin and metronidazole (4 weeks) before switching to HFD for 4 additional weeks. Importantly, the analysis demonstrated that Prevotellaceae and Porphyromonadaceae, two family-level taxa, were undetectable in Asc 2/2 mice 8 weeks after antibiotic treatment ( Supplementary Fig. 12a -c; Supplementary Table 2 ).
To assess whether these metabolic abnormalities are specific to Asc 2/2 mice, we performed similar experiments with Nlrc4 2/2 mice. These mice showed an equal rate of body mass gain, and similar glucose tolerance phenotypes as singly housed wild-type mice, confirming the specificity of the phenotype (Supplementary Fig. 10a-d) .
16S rRNA analysis revealed that there was an increased representation of Porphyromonadaceae in Nlrc4 2/2 mice when compared to wildtype mice ( Supplementary Table 3 ). These results indicate that (1) some metabolic aberrations associated with the dysbiosis of inflammasome-deficient mice can be horizontally transferred from one mouse to another,(2) the gut microbiota of inflammasomedeficient mice has a negative effect on NAFLD progression and glucose homeostasis, and (3) configurational changes in the microbiota, which involve overrepresentation Porphyromonadaceae in combination with alterations in additional taxa, are likely required to produce these host phenotypes.
Discussion
The results presented here provide evidence that modulation of the intestinal microbiota through multiple inflammasome components is a critical determinant of NAFLD/NASH progression as well as multiple other aspects of metabolic syndrome such as weight gain and glucose homeostasis. Our results demonstrate a complex and cooperative effect of two sensing protein families, namely NLRs and TLRs, in shaping metabolic events. In the gut, the combination of hostrelated factors such as genetic inflammasome deficiency-associated dysbiosis result in abnormal accumulation of bacterial products in the portal circulation. The liver, being a 'first pass' organ and thus exposed to the highest concentration of portal system products such as PAMPs, is expected to be most vulnerable to their effects, particularly when pre-conditioned by sub-clinical pathology such as lipid accumulation in hepatocytes. Indeed in our models, accumulation of TLR agonists was sufficient to drive progression of NAFLD/NASH even in genetically intact animals.
This 'gut-liver axis', driven by alterations in gut microbial ecology, may offer an explanation for a number of long-standing, albeit poorly understood, clinical associations. One example is the occurrence of primary sclerosing cholangitis (PSC) in patients with inflammatory bowel disease, particularly those with inflammation along the length of the colon. Coeliac disease, another inflammatory disorder with increased intestinal permeability, is associated with a variety of liver disorders, ranging from asymptomatic transaminasaemia, NAFLD, to primary biliary cirrhosis (PBC). In fully developed cirrhosis, complications associated with high mortality such as portal hypertension, variceal bleeding, spontaneous bacterial peritonitis and encephalopathy are triggered by translocation of bacteria or bacterial components, providing another important example of the importance of the interplay between the microbiome, the immune response and liver pathology 28 .
Recent reports suggest a complex role of inflammasome function in multiple manifestations of the metabolic syndrome. Activation of IL-1b, mainly through cleavage by the NLRP3 inflammasome, promotes insulin resistance 29, 30 , atherosclerotic plaque formation 31 , and b cell death 32, 33 . Moreover, caspase-1 activation seems to direct adipocytes towards a more insulin-resistant phenotype 34 . Conversely, Il18-deficient mice are prone to develop obesity, hyperphagia and insulin resistance 35 . These discrepancies most probably reflect a hierarchical contribution of multiple inflammasome components in different metabolic processes, tissues and mouse models. In agreement with previous studies, we found increased obesity and insulin resistance in Il18-deficient mice fed with a HFD (data not shown). However, and in contrast to two previous reports 30, 34 , we showed that Asc 2/2 mice are prone to obesity induction and hepatosteatosis, as well as impaired glucose homeostasis when fed a HFD. We propose that alterations in intestinal microbiota communities associated with multiple inflammasome deficiencies could account for these discrepancies and it should be added to the list of major environmental/host factors affecting manifestations and progression of metabolic syndrome in susceptible populations.
In the inflammasome-deficient setting, a significant expansion of Porphyromonadaceae was found following administration of MCDD and HFD, which was abolished by antibiotic treatment. Interestingly, one member of the family, Porphyromonas, has been associated with several components of the metabolic syndrome in both mice and humans, including atherosclerosis and diabetes mellitus 36, 37 . Moreover, expansion of this taxa is strongly associated with complications of chronic liver disease 36 . More work is needed to further delineate the relevance of the suggested taxa discovered in our work to the pathogenesis and progression of human NAFLD/NASH and other features of the metabolic syndrome. Elucidation of similar or distinct mechanisms to the ones presented here, possibly linking Porphyromonadaceae expansion to a propensity for development of the metabolic syndrome, would be of importance to the field.
METHODS SUMMARY
Six-to eight-week-old male mice were fed a methionine-choline-deficient diet for 24 days. Eight-to ten-week-old male mice were fed a HFD ad libitum. This diet consists of 60% calories from fat and was administered for 10-12 weeks. Standard histology of liver, terminal ileum and colon were described previously 17 . The presence of immune cells in liver tissue was analysed by flow cytometry on livers digested with 0.5 mg ml 21 collagenase. Glucose tolerance test were performed after 10-12 weeks of consuming the HFD and mice were fasted overnight (,14 h), and injected intraperitoneally with D-glucose. Transmission electron microscopy was performed as previously described 17 . Data are expressed as mean 6 s.e.m. Differences were analysed by Student's t-test or ANOVA and post hoc analysis for multiple group comparison. P values # 0.05 were considered significant.
